ETRI-Knowledge Sharing Plaform

KOREAN
논문 검색
Type SCI
Year ~ Keyword

Detail

Journal Article Barium Titanate Nanoparticles Sensitise Treatment-Resistant Breast Cancer Cells to the Antitumor Action of Tumour-Treating Fields
Cited 24 time in scopus Download 110 time Share share facebook twitter linkedin kakaostory
Authors
Yi Na Yoon, Dae-Sik Lee, Hyung Ju Park, Jae-Sung Kim
Issue Date
2020-02
Citation
Scientific Reports, v.10, pp.1-9
ISSN
2045-2322
Publisher
Nature Research
Language
English
Type
Journal Article
DOI
https://dx.doi.org/10.1038/s41598-020-59445-x
Project Code
19ZS1400, Wearable cancer treatment system using electric field, Dae-Sik Lee
Abstract
Although tumour-treating fields (TTFields) is a promising physical treatment modality based on disruption of dipole alignments and generation of dielectrophoretic forces during cytokinesis, not much is known about TTFields-responsive sensitisers. Here, we report a novel TTFields-responsive sensitiser, barium titanate nanoparticles (BTNPs), which exhibit cytocompatibility, with non-cytotoxic effects on breast cancer cells. BTNPs are characterised by high dielectric constant values and ferroelectric properties. Notably, we found that BTNPs sensitised TTFields-resistant breast cancer cells in response to TTFields. In addition, BTNPs accumulated in the cytoplasm of cancer cells in response to TTFields. Further, we showed that TTFields combined with BTNPs exhibited antitumor activity by modulating several cancer-related pathways in general, and the cell cycle-related apoptosis pathway in particular. Therefore, our data suggest that BTNPs increase the antitumor action of TTFields by an electric field-responsive cytosolic accumulation, establishing BTNP as a TTFields-responsive sensitiser.
KSP Keywords
Apoptosis pathway, Barium titanate nanoparticles, Breast Cancer(BC), Cytotoxic effects, Ferroelectric properties, High dielectric constant, Non-cytotoxic, antitumor activity, breast cancer cells, cell cycle, electric field
This work is distributed under the term of Creative Commons License (CCL)
(CC BY)
CC BY